Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 6
Submit an article Journal homepage
732
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah’s Witnesses

Peter A. Riedella Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2719-0580
ORCID Icon,
Meng Wuc Department of Medicine, University of Chicago, Chicago, IL, USA
,
Jennifer M. Collinsd Department of Pharmacy, University of Chicago, Chicago, IL, USA
,
Jacklyn M. Gideona Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA
,
Andrzej J. Jakubowiaka Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA
,
Justin P. Klinea Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA
,
Satyajit Kosuria Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA
,
Hongtao Liua Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA
,
Sonali M. Smitha Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA
&
Michael R. Bishopa Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA;b David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USAORCID Iconhttps://orcid.org/0000-0002-3979-9273
ORCID Icon show all
Pages 1497-1501 | Received 08 Nov 2020, Accepted 06 Jan 2021, Published online: 03 Feb 2021

References

  • Neelapu SS, Locke FL, Bartlett NL, et al. Axicabtagene Ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N Engl J Med. 2017;377(26):2531–2544.
  • Locke FL, Ghobadi A, Jacobson CA, et al. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial. Lancet Oncol. 2019;20(1):31–42.
  • Schuster SJ, Bishop MR, Tam CS, JULIET Investigators, et al. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N Engl J Med. 2019;380(1):45–56.
  • Abramson JS, Palomba ML, Gordon LI, et al. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study. Lancet. 2020;396:839–852.
  • Axicabtagene Ciloleucel [package insert]. Santa Monica, CA: Kite Pharma; 2017.
  • Tisagenlecleucel [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corp; 2017.
  • JW.org. How Many of Jehovah’s Witnesses Are There Worldwide? 2020. [cited 2020 Sep 12]. Available from: https://www.jw.org/en/jehovahs-witnesses/faq/how-many-jw/.
  • JW.org. Religious and ethical position on medical therapy and related matters. 2020. Available from: https://www.jw.org/en/medical-library/strategies-downloads/religious-and-ethical-position-medical-therapy/.
  • Lee DW, Santomasso BD, Locke FL, et al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant. 2019;25(4):625–638.
  • Fried S, Avigdor A, Bielorai B, et al. Early and late hematologic toxicity following CD19 CAR-T cells. Bone Marrow Transplant. 2019;54(10):1643–1650.
  • Nahas GR, Komanduri KV, Pereira D, et al. Incidence and risk factors associated with a syndrome of persistent cytopenias after CAR-T cell therapy (PCTT). Leuk Lymphoma. 2020;61(4):940–943.
  • Strati P, Varma A, Adkins S, et al. Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma. Haematologica. 2020. [online ahead of print].
  • Ballen KK, Becker PS, Yeap BY, et al. Autologous stem-cell transplantation can be performed safely without the use of blood-product support. J Clin Oncol. 2004;22(20):4087–4094. Oct 15
  • Ford PA, Grant SJ, Mick R, et al. Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's witnesses. J Clin Oncol. 2015;33(15):1674–1679.
  • Grant MD, Piper M, Bohlius J, et al. Epoetin and darbepoetin for managing anemia in patients undergoing cancer treatment: comparative effectiveness update. AHRQ comparative effectiveness reviews. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013.
  • Riedell PA, Walling C, Nastoupil LJ, et al. A multicenter retrospective analysis of outcomes and toxicities with commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive b-cell lymphomas. Biol Blood Marrow Transplant. 2020;26(3):S41–S42.
  • Kochenderfer JN, Somerville RPT, Lu T, et al. Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels. J Clin Oncol. 2017;35(16):1803–1813.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.